Psychiatry
Post-Traumatic Stress Disorder, PTSD
0
Pipeline Programs↗
6
Active Trials↗
4
Companies Involved↗
Post-Traumatic Stress Disorder, PTSD is an early-stage landscape with 0 programs across 4 companies. The most active players are Columbia Northwest Pharmaceuticals, Lundbeck, GSK.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
52
clinical trials
Completed29 · 56%
Unknown status9 · 17%
Recruiting5 · 10%
Terminated5 · 10%
Withdrawn3 · 6%
Not yet recruiting1 · 2%
Clinical Trials
Trial Activity
52 trials
REVERSE: Improving Treatment-resistant Post Traumatic Stress Disorder (PTSD) with Glucocorticoid Receptor (GR) Antagonism
Recruiting·—·Phase 2·NCT06689254·60 enrolled
Transcranial Magnetic Stimulation as Treatment for Persistent PTSD in Texas Youth
Recruiting·TThe University of Texas Health Science Center at San Antonio·Preclinical·NCT07401225·20 enrolled
A Dose Escalation Study of Intranasal Neuropeptide Y in Post Traumatic Stress Disorder (PTSD)
Completed·—·Phase 1·NCT01533519·26 enrolled
Page 1 of 4
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)